Echinocandin Antifungal [EPC]

Echinocandin Antifungal [EPC] was reported 8210 times

Drugs of the Echinocandin Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 WEISSELLA INFECTION 7 0.6364
3 PRE-ENGRAFTMENT IMMUNE REACTION 44 0.5500
4 PULMONARY TRICHOSPORONOSIS 8 0.3478
5 PROTOTHECOSIS 26 0.2766
6 GEOTRICHUM INFECTION 51 0.2417
7 AORTOENTERIC FISTULA 13 0.2031
8 CORYNEBACTERIUM BACTERAEMIA 17 0.2000
9 GASTROINTESTINAL MUCORMYCOSIS 25 0.1497
10 CEREBRAL VENTRICLE COLLAPSE 10 0.1333
11 TRICHOSPORON INFECTION 46 0.1136
12 FUNGAL ENDOCARDITIS 34 0.1130
13 DISSEMINATED MUCORMYCOSIS 44 0.1117
14 MYCOTIC ENDOPHTHALMITIS 21 0.1111
15 INTRACRANIAL INFECTION 13 0.1040
16 SEPTAL PANNICULITIS 8 0.1000
17 PULMONARY MUCORMYCOSIS 52 0.0985
18 FUSARIUM INFECTION 68 0.0971
19 FLUOROSIS 8 0.0930
20 MENINGITIS ENTEROCOCCAL 7 0.0886
21 HEPATIC CANDIDIASIS 6 0.0882
22 ADRENERGIC SYNDROME 7 0.0864
23 SCEDOSPORIUM INFECTION 60 0.0850
24 ENDOCARDITIS CANDIDA 6 0.0789
25 BLOOD BETA-D-GLUCAN INCREASED 24 0.0782
26 PERIOSTITIS 31 0.0718
27 ENGRAFT FAILURE 20 0.0697
28 GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0692
29 HEPATOSPLENIC CANDIDIASIS 10 0.0680
30 FUNGAEMIA 107 0.0679
31 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
32 CEREBRAL ASPERGILLOSIS 40 0.0650
33 RHINOCEREBRAL MUCORMYCOSIS 21 0.0605
34 NASAL FLARING 8 0.0593
35 BILOMA 8 0.0567
36 ENCEPHALITIS FUNGAL 5 0.0556
37 DISSEMINATED ASPERGILLOSIS 26 0.0551
38 CYSTITIS VIRAL 21 0.0548
39 CRYPTOCOCCAL MENINGOENCEPHALITIS 7 0.0534
40 SYSTEMIC MYCOSIS 61 0.0522
41 SYSTEMIC CANDIDA 130 0.0517
42 IDIOPATHIC PNEUMONIA SYNDROME 15 0.0503
43 FUNGAL DISEASE CARRIER 5 0.0495
44 CANDIDA ENDOPHTHALMITIS 6 0.0492
45 HAEMOSTASIS 8 0.0491
46 ASPERGILLUS TEST POSITIVE 15 0.0487
47 BURKHOLDERIA TEST POSITIVE 6 0.0484
48 MUCORMYCOSIS 125 0.0481
49 NASAL ABSCESS 11 0.0476
50 GASTROINTESTINAL FUNGAL INFECTION 24 0.0466
51 HYPEROXALURIA 8 0.0465
52 SEPTIC PULMONARY EMBOLISM 9 0.0462
53 HUMAN HERPESVIRUS 6 ENCEPHALITIS 13 0.0458
54 LYMPHOID TISSUE HYPOPLASIA 7 0.0458
55 ENTEROCOCCAL SEPSIS 37 0.0457
56 ENCEPHALITIS VIRAL 55 0.0452
57 PHAEHYPHOMYCOSIS 6 0.0448
58 STENOTROPHOMONAS TEST POSITIVE 6 0.0448
59 ABDOMINAL WOUND DEHISCENCE 12 0.0440
60 CUTANEOUS MUCORMYCOSIS 8 0.0435
61 ADENOVIRAL HAEMORRHAGIC CYSTITIS 9 0.0433
62 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 10 0.0431
63 ADENOVIRAL HEPATITIS 10 0.0426
64 THYMUS HYPOPLASIA 7 0.0402
65 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 56 0.0396
66 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 28 0.0389
67 CEREBRAL FUNGAL INFECTION 11 0.0389
68 BACTERIAL TOXAEMIA 5 0.0388
69 CANDIDA TEST POSITIVE 16 0.0383
70 MORGANELLA INFECTION 11 0.0375
71 CITROBACTER INFECTION 16 0.0373
72 LACTOBACILLUS INFECTION 6 0.0366
73 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 100 0.0361
74 HUMAN HERPESVIRUS 6 INFECTION 66 0.0349
75 EYE INFECTION FUNGAL 13 0.0336
76 ALLERGIC TRANSFUSION REACTION 5 0.0331
77 ANTITHROMBIN III DECREASED 9 0.0330
78 CYTOMEGALOVIRUS TEST POSITIVE 58 0.0325
79 GRAFT VERSUS HOST DISEASE IN LIVER 23 0.0321
80 ALLOGENIC STEM CELL TRANSPLANTATION 5 0.0316
81 HEPATIC VEIN OCCLUSION 5 0.0316
82 BACTERIAL TRANSLOCATION 10 0.0315
83 ASPERGILLUS INFECTION 205 0.0312
84 SINUSITIS FUNGAL 25 0.0312
85 PARENTERAL NUTRITION 7 0.0303
86 OSTEOMYELITIS FUNGAL 5 0.0299
87 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 5 0.0289
88 ABSCESS FUNGAL 5 0.0286
89 PLASMA CELL LEUKAEMIA 17 0.0283
90 INFECTIVE ANEURYSM 14 0.0283
91 BRONCHOPULMONARY ASPERGILLOSIS 215 0.0277
92 ENGRAFTMENT SYNDROME 16 0.0271
93 MENINGOENCEPHALITIS HERPETIC 12 0.0268
94 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 6 0.0267
95 DISSEMINATED CRYPTOCOCCOSIS 20 0.0264
96 NECROTISING OESOPHAGITIS 13 0.0261
97 SINUS POLYP 15 0.0260
98 GASTROINTESTINAL MUCOSAL DISORDER 17 0.0260
99 FACTOR V INHIBITION 5 0.0258
100 ACUTE MYELOID LEUKAEMIA RECURRENT 55 0.0256
101 ENTEROCOCCAL INFECTION 123 0.0254
102 VIRAL HAEMORRHAGIC CYSTITIS 18 0.0253
103 PYROGLUTAMIC ACIDOSIS 10 0.0252
104 PNEUMONIA FUNGAL 98 0.0248
105 ENCEPHALITIS HERPES 12 0.0243
106 KLEBSIELLA BACTERAEMIA 23 0.0242
107 ALTERNARIA INFECTION 9 0.0242
108 RECTAL PERFORATION 13 0.0241
109 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 5 0.0240
110 DELAYED GRAFT FUNCTION 17 0.0239
111 GLOMERULOSCLEROSIS 15 0.0237
112 INFECTION IN AN IMMUNOCOMPROMISED HOST 17 0.0237
113 STENOTROPHOMONAS INFECTION 32 0.0236
114 ZYGOMYCOSIS 11 0.0235
115 BRAIN ABSCESS 58 0.0229
116 ENTEROCOCCAL BACTERAEMIA 24 0.0226
117 HUMAN POLYOMAVIRUS INFECTION 12 0.0226
118 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 9 0.0222
119 CYTOMEGALOVIRUS ENTEROCOLITIS 17 0.0221
120 PRIMARY MYELOFIBROSIS 7 0.0217
121 FUNGAL SEPSIS 18 0.0217
122 ENTEROCOCCUS TEST POSITIVE 14 0.0216
123 HERPES SIMPLEX HEPATITIS 5 0.0209
124 OPHTHALMIC VEIN THROMBOSIS 5 0.0207
125 CARDIAC VALVE VEGETATION 10 0.0206
126 PULMONARY MYCOSIS 16 0.0205
127 ACUTE GRAFT VERSUS HOST DISEASE 94 0.0205
128 ASPARTATE AMINOTRANSFERASE 5 0.0205
129 ECTHYMA 8 0.0200
130 MUCOSAL EROSION 18 0.0198
131 TRACHEOBRONCHITIS 15 0.0195
132 BRONCHIAL HAEMORRHAGE 6 0.0192
133 MYCOPLASMA INFECTION 15 0.0192
134 CRYPTOSPORIDIOSIS INFECTION 10 0.0190
135 CANDIDA SEPSIS 17 0.0190
136 DEVICE RELATED SEPSIS 38 0.0189
137 PSEUDOMONAL SEPSIS 33 0.0188
138 REACTIVE GASTROPATHY 7 0.0183
139 BACTERIAL SEPSIS 57 0.0175
140 MEDIASTINITIS 10 0.0172
141 GRAFT VERSUS HOST DISEASE IN SKIN 38 0.0172
142 DYSBIOSIS 14 0.0171
143 FUNGAL OESOPHAGITIS 12 0.0170
144 SEPTIC EMBOLUS 14 0.0168
145 CORYNEBACTERIUM INFECTION 9 0.0168
146 GRAFT VERSUS HOST DISEASE IN LUNG 8 0.0167
147 INFECTIOUS PLEURAL EFFUSION 25 0.0164
148 DIFFERENTIATION SYNDROME 12 0.0163
149 LINEAR IGA DISEASE 27 0.0162
150 BACTERIURIA 9 0.0159
151 KLEBSIELLA INFECTION 77 0.0152
152 MULTIPLE ORGAN DYSFUNCTION SYNDROME 431 0.0152
153 STAPHYLOCOCCAL BACTERAEMIA 66 0.0152
154 VENOOCCLUSIVE LIVER DISEASE 74 0.0150
155 HYPOPERFUSION 15 0.0143
156 CYTOMEGALOVIRUS HEPATITIS 5 0.0141
157 CANDIDA INFECTION 237 0.0140
158 CHRONIC GRAFT VERSUS HOST DISEASE 49 0.0136
159 CYTOMEGALOVIRUS VIRAEMIA 60 0.0135
160 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 5 0.0132
161 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 43 0.0130
162 PSEUDOMONAL BACTERAEMIA 11 0.0129
163 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
164 HAEMORRHAGIC INFARCTION 7 0.0128
165 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 27 0.0127
166 ENTEROBACTER INFECTION 21 0.0125
167 CAT SCRATCH DISEASE 5 0.0124
168 ASPERGILLOSIS 16 0.0122
169 GRAFT VERSUS HOST DISEASE 87 0.0121
170 PNEUMONIA KLEBSIELLA 22 0.0120
171 HYPOGONADISM 12 0.0119
172 PATHOGEN RESISTANCE 107 0.0117
173 ESCHERICHIA SEPSIS 34 0.0117
174 ENTEROVIRUS INFECTION 10 0.0116
175 HYPHAEMA 6 0.0115
176 PULMONARY CAVITATION 10 0.0115
177 CHOLESTATIC LIVER INJURY 25 0.0112
178 OESOPHAGEAL INFECTION 5 0.0112
179 NEUTROPENIC COLITIS 23 0.0111
180 ESCHERICHIA BACTERAEMIA 26 0.0110
181 ACINETOBACTER INFECTION 12 0.0110
182 BOTULISM 9 0.0109
183 CHORIORETINITIS 7 0.0109
184 LIVER ABSCESS 35 0.0108
185 HAEMATOLOGICAL INFECTION 26 0.0106
186 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 79 0.0105
187 NEUTROPENIC INFECTION 10 0.0104
188 BLASTOMYCOSIS 5 0.0103
189 HAEMOPHILUS INFECTION 10 0.0102
190 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 18 0.0102
191 LUNG CONSOLIDATION 28 0.0100
192 METABOLIC ALKALOSIS 16 0.0100
193 CYSTITIS HAEMORRHAGIC 40 0.0099
194 OBLITERATIVE BRONCHIOLITIS 13 0.0099
195 PNEUMONIA PSEUDOMONAL 15 0.0098
196 PROTEUS INFECTION 7 0.0097
197 VASOGENIC CEREBRAL OEDEMA 7 0.0097
198 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0097
199 CENTRAL NERVOUS SYSTEM INFECTION 11 0.0096
200 DISSEMINATED INTRAVASCULAR COAGULATION 135 0.0096
201 BACILLUS INFECTION 6 0.0095
202 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
203 POLYOMAVIRUS VIRAEMIA 10 0.0094
204 STAPHYLOCOCCAL SEPSIS 46 0.0093
205 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 24 0.0093
206 PNEUMONIA NECROTISING 6 0.0093
207 VASCULAR DEVICE INFECTION 42 0.0092
208 KLEBSIELLA TEST POSITIVE 6 0.0092
209 CRYSTALLURIA 5 0.0092
210 LUNG TRANSPLANT REJECTION 6 0.0091
211 EMPYEMA 18 0.0090
212 ADENOVIRUS INFECTION 26 0.0090
213 PSEUDOMEMBRANOUS COLITIS 20 0.0089
214 METAPNEUMOVIRUS INFECTION 7 0.0089
215 BLOOD FIBRINOGEN INCREASED 7 0.0089
216 COLONIC FISTULA 5 0.0088
217 VENOOCCLUSIVE DISEASE 22 0.0088
218 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
219 PERFORATION 7 0.0087
220 BACTERAEMIA 103 0.0087
221 KIDNEY FIBROSIS 15 0.0086
222 BLAST CELL COUNT INCREASED 9 0.0086
223 RENAL ABSCESS 7 0.0085
224 MALIGNANT PERITONEAL NEOPLASM 5 0.0085
225 TOXOPLASMOSIS 9 0.0083
226 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 10 0.0083
227 STREPTOCOCCAL BACTERAEMIA 9 0.0083
228 SEPTIC SHOCK 356 0.0082
229 TRANSPLANT FAILURE 20 0.0081
230 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 48 0.0081
231 MUCOUS MEMBRANE DISORDER 11 0.0080
232 BRAIN HERNIATION 24 0.0080
233 RHINOVIRUS INFECTION 31 0.0080
234 EPSTEIN-BARR VIRUS TEST POSITIVE 5 0.0079
235 SPINAL CORD DISORDER 13 0.0079
236 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
237 HAEMODYNAMIC INSTABILITY 59 0.0077
238 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
239 HYPERMAGNESAEMIA 5 0.0077
240 ENDOCARDITIS BACTERIAL 6 0.0076
241 ILEAL PERFORATION 5 0.0075
242 THROMBOTIC MICROANGIOPATHY 73 0.0075
243 SMALL INTESTINAL HAEMORRHAGE 15 0.0074
244 MENINGITIS CRYPTOCOCCAL 13 0.0074
245 BK VIRUS INFECTION 25 0.0074
246 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
247 BLOOD CULTURE POSITIVE 22 0.0073
248 CYTOMEGALOVIRUS INFECTION 122 0.0073
249 ISCHAEMIC HEPATITIS 10 0.0073
250 FEBRILE NEUTROPENIA 482 0.0073
251 CYTOKINE RELEASE SYNDROME 143 0.0071
252 ENTHESOPATHY 11 0.0070
253 ACUTE SINUSITIS 12 0.0070
254 ORAL FUNGAL INFECTION 19 0.0069
255 FUNGAL SKIN INFECTION 28 0.0069
256 INCISION SITE PAIN 8 0.0068
257 CLOSTRIDIUM TEST POSITIVE 15 0.0068
258 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 18 0.0068
259 RESPIRATORY ALKALOSIS 11 0.0068
260 CRYPTOCOCCOSIS 11 0.0067
261 SKIN NECROSIS 35 0.0067
262 SECONDARY IMMUNODEFICIENCY 8 0.0066
263 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
264 CELL DEATH 13 0.0065
265 WOUND DEHISCENCE 22 0.0065
266 LEUKAEMIA RECURRENT 11 0.0065
267 DRUG RESISTANCE 166 0.0065
268 HYPOALBUMINAEMIA 50 0.0064
269 HYPERBILIRUBINAEMIA 66 0.0064
270 MEGACOLON 10 0.0064
271 ATYPICAL MYCOBACTERIAL INFECTION 9 0.0064
272 FUNCTIONAL GASTROINTESTINAL DISORDER 22 0.0064
273 RESPIRATORY ACIDOSIS 25 0.0064
274 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 6 0.0063
275 HYPERURICAEMIA 26 0.0063
276 APLASTIC ANAEMIA 33 0.0063
277 EPSTEIN-BARR VIRAEMIA 7 0.0063
278 MENINGITIS BACTERIAL 9 0.0063
279 CAPILLARY LEAK SYNDROME 13 0.0063
280 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 24 0.0063
281 KLEBSIELLA SEPSIS 7 0.0062
282 RED BLOOD CELLS URINE POSITIVE 6 0.0062
283 ACUTE RESPIRATORY DISTRESS SYNDROME 108 0.0061
284 FUNGAL PERITONITIS 9 0.0059
285 STREPTOCOCCAL SEPSIS 7 0.0059
286 ENTERITIS INFECTIOUS 10 0.0059
287 TUMOUR LYSIS SYNDROME 51 0.0058
288 NEPHROPATHY TOXIC 65 0.0058
289 HYPOGAMMAGLOBULINAEMIA 38 0.0058
290 VIRAEMIA 8 0.0058
291 PERITONEAL HAEMORRHAGE 8 0.0058
292 PSEUDOMONAS INFECTION 49 0.0057
293 ENTEROCUTANEOUS FISTULA 5 0.0057
294 IMPRISONMENT 10 0.0057
295 ACUTE LYMPHOCYTIC LEUKAEMIA 16 0.0056
296 HYPERLEUKOCYTOSIS 5 0.0056
297 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
298 BILIRUBIN CONJUGATED INCREASED 13 0.0056
299 ORGAN FAILURE 22 0.0055
300 INTRA-ABDOMINAL HAEMORRHAGE 13 0.0055
301 SHOCK HAEMORRHAGIC 44 0.0054
302 SUSPECTED OFF LABEL USE 24 0.0053
303 VITH NERVE PARALYSIS 6 0.0053
304 TRANSPLANT REJECTION 42 0.0052
305 HYPERTRANSAMINASAEMIA 36 0.0052
306 PULMONARY ALVEOLAR HAEMORRHAGE 29 0.0052
307 MULTI-ORGAN DISORDER 10 0.0051
308 CEREBRAL HAEMATOMA 17 0.0051
309 HYPOFIBRINOGENAEMIA 5 0.0050
310 HEPATIC NECROSIS 19 0.0050
311 FUNGAL INFECTION 168 0.0050
312 SERUM SICKNESS 14 0.0050
313 ESCHERICHIA TEST POSITIVE 6 0.0050
314 ACUTE MYELOID LEUKAEMIA 78 0.0050
315 PNEUMOMEDIASTINUM 9 0.0050
316 HYPOCHROMIC ANAEMIA 5 0.0049
317 LUNG OPACITY 13 0.0049
318 MULTI-ORGAN FAILURE 84 0.0049
319 BLOOD UREA DECREASED 6 0.0048
320 PULMONARY SEPSIS 7 0.0048
321 LUNG ABSCESS 10 0.0048
322 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 24 0.0047
323 TOXIC EPIDERMAL NECROLYSIS 71 0.0047
324 PLATELET TRANSFUSION 6 0.0047
325 EPSTEIN-BARR VIRUS INFECTION 29 0.0046
326 CONCOMITANT DISEASE PROGRESSION 9 0.0046
327 APLASIA 9 0.0046
328 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 6 0.0046
329 PULSELESS ELECTRICAL ACTIVITY 19 0.0045
330 THROMBOTIC THROMBOCYTOPENIC PURPURA 16 0.0045
331 CATHETER SITE INFECTION 17 0.0045
332 PARESIS 10 0.0045
333 HYPERLACTACIDAEMIA 12 0.0045
334 PULMONARY HAEMORRHAGE 35 0.0045
335 HISTOPLASMOSIS DISSEMINATED 7 0.0044
336 COVID-19 PNEUMONIA 52 0.0044
337 PNEUMOCYSTIS JIROVECII PNEUMONIA 44 0.0044
338 NEUROLOGICAL SYMPTOM 25 0.0044
339 INFECTION REACTIVATION 5 0.0044
340 PNEUMONIA BACTERIAL 40 0.0044
341 URINARY TRACT INFECTION BACTERIAL 11 0.0043
342 CYTOMEGALOVIRUS COLITIS 10 0.0043
343 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
344 RESPIRATORY FAILURE 308 0.0042
345 HYPERNATRAEMIA 21 0.0042
346 DRUG LEVEL BELOW THERAPEUTIC 23 0.0042
347 PNEUMONIA CYTOMEGALOVIRAL 8 0.0041
348 CYTOMEGALOVIRUS CHORIORETINITIS 8 0.0041
349 MONOCYTE COUNT DECREASED 5 0.0041
350 BACTERIAL INFECTION 76 0.0041
351 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
352 ACUTE PSYCHOSIS 10 0.0040
353 BACTERIAL TEST POSITIVE 9 0.0040
354 OLIGURIA 25 0.0040
355 ACUTE RESPIRATORY FAILURE 77 0.0040
356 INTESTINAL ISCHAEMIA 22 0.0040
357 MIXED LIVER INJURY 12 0.0040
358 HYPERCAPNIA 12 0.0040
359 LIVER TRANSPLANT REJECTION 7 0.0039
360 CLOSTRIDIUM DIFFICILE COLITIS 41 0.0039
361 SEPSIS 427 0.0038
362 NON-HODGKIN'S LYMPHOMA 5 0.0038
363 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 19 0.0038
364 GASTROENTERITIS NOROVIRUS 5 0.0038
365 ADENOCARCINOMA OF COLON 7 0.0037
366 MYCOBACTERIUM AVIUM COMPLEX INFECTION 10 0.0037
367 BRAIN OEDEMA 47 0.0037
368 STRONGYLOIDIASIS 6 0.0037
369 INTERVERTEBRAL DISCITIS 7 0.0037
370 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 8 0.0036
371 BILIARY TRACT DISORDER 5 0.0036
372 RASH MORBILLIFORM 10 0.0036
373 SERUM FERRITIN INCREASED 19 0.0036
374 DEVICE RELATED INFECTION 55 0.0036
375 MUCOSAL INFLAMMATION 93 0.0035
376 MULTIPLE-DRUG RESISTANCE 11 0.0035
377 GASTROINTESTINAL TOXICITY 17 0.0035
378 ABDOMINAL INFECTION 9 0.0035
379 ENDOCARDITIS 18 0.0035
380 MYCOBACTERIAL INFECTION 6 0.0035
381 NEUROLOGICAL DECOMPENSATION 8 0.0035
382 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
383 PANCYTOPENIA 192 0.0034
384 CYTOMEGALOVIRUS INFECTION REACTIVATION 15 0.0034
385 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
386 TORSADE DE POINTES 26 0.0033
387 HYDROCEPHALUS 18 0.0033
388 HYPOXIA 116 0.0033
389 ESCHERICHIA INFECTION 27 0.0033
390 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
391 ORAL DISORDER 24 0.0033
392 HYPERPHOSPHATAEMIA 7 0.0033
393 MEAN CELL VOLUME DECREASED 5 0.0032
394 GRANULOCYTE COUNT DECREASED 6 0.0032
395 MYELITIS 5 0.0032
396 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
397 ENDOTRACHEAL INTUBATION 9 0.0032
398 ATELECTASIS 31 0.0032
399 BLOOD CREATININE DECREASED 10 0.0032
400 COAGULOPATHY 53 0.0032
401 LARGE INTESTINE PERFORATION 22 0.0032
402 ABDOMINAL ABSCESS 14 0.0032
403 RETROPERITONEAL HAEMATOMA 7 0.0032
404 OESOPHAGEAL STENOSIS 9 0.0032
405 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
406 BLOOD ALBUMIN DECREASED 25 0.0031
407 SPINAL STENOSIS 13 0.0031
408 ACIDOSIS 24 0.0031
409 ANURIA 27 0.0031
410 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0031
411 DISSEMINATED TUBERCULOSIS 8 0.0031
412 BLOOD UREA INCREASED 52 0.0031
413 CYTOPENIA 38 0.0031
414 GASTROINTESTINAL NECROSIS 9 0.0031
415 SHOCK 71 0.0031
416 BLOOD BILIRUBIN INCREASED 83 0.0031
417 STEVENS-JOHNSON SYNDROME 68 0.0031
418 GENE MUTATION 6 0.0030
419 ORGANISING PNEUMONIA 15 0.0030
420 HAEMOLYTIC URAEMIC SYNDROME 7 0.0030
421 CANDIDIASIS 12 0.0030
422 WOUND HAEMORRHAGE 11 0.0030
423 HEPATIC FUNCTION ABNORMAL 111 0.0030
424 HYPOKALAEMIA 136 0.0029
425 TACHYPNOEA 40 0.0029
426 STAPHYLOCOCCAL INFECTION 97 0.0029
427 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
428 DIABETES INSIPIDUS 7 0.0029
429 ENCEPHALITIS 20 0.0029
430 MYELOSUPPRESSION 103 0.0029
431 PLEURAL EFFUSION 171 0.0028
432 PURULENT DISCHARGE 12 0.0028
433 MONOPARESIS 5 0.0028
434 PULMONARY MASS 41 0.0027
435 DRUG LEVEL DECREASED 28 0.0027
436 GENERALISED OEDEMA 34 0.0027
437 LYMPHOPROLIFERATIVE DISORDER 8 0.0027
438 OTOTOXICITY 5 0.0027
439 ILEUS PARALYTIC 12 0.0027
440 HEPATIC FAILURE 81 0.0027
441 MALNUTRITION 30 0.0027
442 ASPARTATE AMINOTRANSFERASE INCREASED 142 0.0027
443 OESOPHAGITIS 29 0.0027
444 PNEUMOTHORAX 42 0.0026
445 PROCTALGIA 17 0.0026
446 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
447 LUNG INFECTION 41 0.0026
448 HYPERVOLAEMIA 13 0.0026
449 LUNG INFILTRATION 23 0.0026
450 LYMPHOCYTE COUNT DECREASED 46 0.0026
451 VASCULITIS 30 0.0026
452 PSYCHIATRIC SYMPTOM 19 0.0026
453 HYPOPHOSPHATAEMIA 19 0.0026
454 ENCEPHALOPATHY 63 0.0026
455 BLOOD PHOSPHORUS INCREASED 7 0.0026
456 NECROTISING FASCIITIS 9 0.0026
457 SUBARACHNOID HAEMORRHAGE 26 0.0026
458 CARDIAC FAILURE ACUTE 17 0.0025
459 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 140 0.0025
460 LACUNAR INFARCTION 6 0.0025
461 STUPOR 8 0.0025
462 PERICARDIAL EFFUSION 56 0.0024
463 INFLAMMATORY MARKER INCREASED 12 0.0024
464 STEM CELL TRANSPLANT 6 0.0024
465 NEUROTOXICITY 42 0.0024
466 ALANINE AMINOTRANSFERASE INCREASED 147 0.0024
467 NEUTROPENIA 322 0.0024
468 BONE MARROW FAILURE 48 0.0024
469 HEPATIC CYST 8 0.0024
470 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
471 CACHEXIA 12 0.0023
472 DRUG ERUPTION 41 0.0023
473 FAILURE TO THRIVE 12 0.0023
474 NOSOCOMIAL INFECTION 5 0.0023
475 ATRIAL FLUTTER 18 0.0023
476 RENAL IMPAIRMENT 189 0.0022
477 HEPATOTOXICITY 50 0.0022
478 BLOOD SODIUM INCREASED 6 0.0022
479 HYPERTRIGLYCERIDAEMIA 13 0.0022
480 DIFFUSE LARGE B-CELL LYMPHOMA 17 0.0022
481 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
482 HYPERLIPIDAEMIA 26 0.0022
483 PROTHROMBIN TIME PROLONGED 13 0.0022
484 TOXIC ENCEPHALOPATHY 11 0.0022
485 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
486 METHAEMOGLOBINAEMIA 5 0.0022
487 METABOLIC ACIDOSIS 69 0.0022
488 STREPTOCOCCAL INFECTION 12 0.0022
489 LEUKOCYTOSIS 39 0.0022
490 RENAL TUBULAR NECROSIS 21 0.0021
491 RESPIRATORY DISTRESS 59 0.0021
492 DRUG-INDUCED LIVER INJURY 67 0.0021
493 PROTEIN TOTAL DECREASED 8 0.0021
494 NEUTROPENIC SEPSIS 15 0.0021
495 AGRANULOCYTOSIS 39 0.0021
496 MENINGITIS 14 0.0021
497 PANCREATITIS ACUTE 47 0.0021
498 HYPOVOLAEMIC SHOCK 10 0.0021
499 LONG QT SYNDROME 5 0.0021
500 ENTEROCOLITIS 12 0.0021
501 PERITONITIS 43 0.0021
502 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
503 HEPARIN-INDUCED THROMBOCYTOPENIA 10 0.0020
504 HYPERCALCAEMIA 25 0.0020
505 ACUTE KIDNEY INJURY 307 0.0020
506 LEUKOPENIA 100 0.0020
507 FLUID OVERLOAD 29 0.0020
508 LUNG TRANSPLANT 7 0.0020
509 FIBRIN D DIMER INCREASED 7 0.0020
510 NOCARDIOSIS 5 0.0020
511 NEUTROPHIL COUNT INCREASED 20 0.0020
512 HEPATOSPLENOMEGALY 5 0.0019
513 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
514 EOSINOPHILIA 34 0.0019
515 NEUTROPHIL COUNT DECREASED 79 0.0019
516 VENTRICULAR TACHYCARDIA 32 0.0019
517 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
518 TRANSAMINASES INCREASED 42 0.0019
519 FEBRILE BONE MARROW APLASIA 8 0.0019
520 HYPOTHERMIA 19 0.0019
521 ASCITES 55 0.0019
522 BLOOD CALCIUM DECREASED 21 0.0019
523 HAEMOPTYSIS 52 0.0019
524 PORTAL VEIN THROMBOSIS 6 0.0019
525 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
526 DECUBITUS ULCER 15 0.0018
527 CHOLESTASIS 35 0.0018
528 CIRCULATORY COLLAPSE 31 0.0018
529 PROTEIN URINE PRESENT 9 0.0018
530 HYPERAMMONAEMIA 9 0.0018
531 DERMATITIS BULLOUS 13 0.0018
532 HYPOMAGNESAEMIA 25 0.0018
533 CHOLANGITIS 11 0.0018
534 CLOSTRIDIAL INFECTION 6 0.0018
535 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
536 OESOPHAGEAL CANDIDIASIS 7 0.0018
537 ORAL CANDIDIASIS 23 0.0017
538 C-REACTIVE PROTEIN INCREASED 63 0.0017
539 HEMIPARESIS 29 0.0017
540 RASH MACULO-PAPULAR 38 0.0017
541 CEREBRAL HAEMORRHAGE 61 0.0017
542 PAPULE 12 0.0017
543 ABSCESS 27 0.0017
544 CONJUNCTIVAL HYPERAEMIA 6 0.0017
545 PYREXIA 580 0.0017
546 SUBCUTANEOUS ABSCESS 8 0.0017
547 LIVER DISORDER 73 0.0016
548 MOUTH HAEMORRHAGE 12 0.0016
549 THROMBOCYTOPENIA 183 0.0016
550 DUODENITIS 5 0.0016
551 SPLENOMEGALY 19 0.0016
552 BRAIN DEATH 5 0.0016
553 NECROSIS 9 0.0016
554 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
555 INTERSTITIAL LUNG DISEASE 78 0.0016
556 ACUTE HEPATIC FAILURE 22 0.0016
557 HAEMORRHAGE INTRACRANIAL 24 0.0016
558 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
559 MELAENA 35 0.0016
560 TOXIC SKIN ERUPTION 16 0.0016
561 ELECTROCARDIOGRAM QT PROLONGED 57 0.0016
562 SPINAL COMPRESSION FRACTURE 13 0.0016
563 OESOPHAGEAL ULCER 6 0.0016
564 CEREBRAL ISCHAEMIA 8 0.0016
565 STRESS CARDIOMYOPATHY 9 0.0015
566 HERPES SIMPLEX 10 0.0015
567 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
568 MYELODYSPLASTIC SYNDROME 22 0.0015
569 BLOOD LACTIC ACID INCREASED 8 0.0015
570 POLYDIPSIA 6 0.0015
571 CLOSTRIDIUM DIFFICILE INFECTION 33 0.0015
572 DRUG LEVEL INCREASED 25 0.0015
573 MENTAL STATUS CHANGES 41 0.0015
574 PERIPHERAL ISCHAEMIA 6 0.0015
575 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
576 ARTHRITIS BACTERIAL 6 0.0015
577 PRODUCT USE IN UNAPPROVED INDICATION 362 0.0015
578 KIDNEY TRANSPLANT REJECTION 7 0.0015
579 LACTIC ACIDOSIS 47 0.0014
580 ILEUS 18 0.0014
581 CEREBRAL INFARCTION 35 0.0014
582 INCORRECT DOSAGE ADMINISTERED 7 0.0014
583 RENAL FAILURE 190 0.0014
584 HAEMOLYSIS 11 0.0014
585 PRODUCT PRESCRIBING ISSUE 31 0.0014
586 HAEMATOCRIT DECREASED 28 0.0014
587 HAEMORRHAGIC DIATHESIS 5 0.0014
588 HEPATIC ENZYME ABNORMAL 7 0.0014
589 DISEASE PROGRESSION 165 0.0014
590 METABOLIC DISORDER 8 0.0014
591 DIVERTICULUM INTESTINAL 6 0.0014
592 HYPERKALAEMIA 48 0.0014
593 HYPOVOLAEMIA 8 0.0014
594 IMMUNOSUPPRESSION 12 0.0014
595 LIVER FUNCTION TEST INCREASED 29 0.0013
596 CARDIAC DYSFUNCTION 5 0.0013
597 LYMPHOPENIA 19 0.0013
598 PLATELET COUNT DECREASED 143 0.0013
599 TONSILLITIS 7 0.0013
600 IRON DEFICIENCY 6 0.0013
601 POSTOPERATIVE WOUND INFECTION 9 0.0013
602 PNEUMONIA ASPIRATION 33 0.0013
603 NEPHROTIC SYNDROME 9 0.0013
604 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
605 UROSEPSIS 12 0.0013
606 BRUXISM 7 0.0013
607 LYMPHOMA 20 0.0013
608 NEPHROPATHY 12 0.0013
609 APPENDICITIS 12 0.0013
610 FAECALOMA 7 0.0013
611 PULMONARY TOXICITY 9 0.0013
612 CARDIAC ARREST 105 0.0013
613 INFECTION 184 0.0013
614 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
615 URINE OUTPUT DECREASED 11 0.0013
616 BLOOD CREATININE INCREASED 82 0.0013
617 CONTRAINDICATED PRODUCT ADMINISTERED 38 0.0013
618 AZOTAEMIA 5 0.0013
619 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
620 PNEUMONITIS 34 0.0012
621 DRUG INTERACTION 198 0.0012
622 ACUTE PULMONARY OEDEMA 7 0.0012
623 BLOOD URIC ACID INCREASED 7 0.0012
624 DELIRIUM 42 0.0012
625 CORONAVIRUS INFECTION 8 0.0012
626 ELECTROLYTE IMBALANCE 14 0.0012
627 HYDRONEPHROSIS 9 0.0012
628 UNRESPONSIVE TO STIMULI 31 0.0012
629 DERMATITIS EXFOLIATIVE 6 0.0012
630 PNEUMONIA 388 0.0012
631 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
632 BRONCHIECTASIS 8 0.0012
633 LIPASE INCREASED 9 0.0012
634 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
635 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 30 0.0012
636 COLITIS 44 0.0012
637 THERAPY NON-RESPONDER 52 0.0012
638 RENAL FAILURE ACUTE 49 0.0012
639 HAEMORRHAGIC STROKE 9 0.0012
640 MALABSORPTION 6 0.0011
641 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
642 RIGHT VENTRICULAR FAILURE 8 0.0011
643 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
644 DRUG INEFFECTIVE 1486 0.0011
645 HEPATOMEGALY 11 0.0011
646 ANAL ABSCESS 6 0.0011
647 TREATMENT FAILURE 92 0.0011
648 ENTERITIS 7 0.0011
649 NERVOUS SYSTEM DISORDER 34 0.0011
650 STOMATITIS 66 0.0011
651 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
652 CELLULITIS 54 0.0011
653 ADRENAL INSUFFICIENCY 13 0.0011
654 INTESTINAL PERFORATION 12 0.0011
655 CHOLECYSTITIS ACUTE 6 0.0011
656 HYPOCALCAEMIA 20 0.0011
657 SMALL INTESTINAL OBSTRUCTION 13 0.0011
658 PETECHIAE 11 0.0011
659 WHITE BLOOD CELL COUNT DECREASED 114 0.0011
660 SKIN MASS 7 0.0010
661 HYPONATRAEMIA 59 0.0010
662 OFF LABEL USE 902 0.0010
663 LIVER INJURY 25 0.0010
664 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
665 CARDIOTOXICITY 9 0.0010
666 ANAEMIA 192 0.0010
667 ENDOPHTHALMITIS 6 0.0010
668 HYPOTENSION 200 0.0010
669 MIOSIS 8 0.0010
670 HEPATITIS CHOLESTATIC 6 0.0010
671 VENTRICULAR FIBRILLATION 11 0.0010
672 DYSPHORIA 5 0.0010
673 PULMONARY OEDEMA 44 0.0010
674 SUBDURAL HAEMATOMA 14 0.0010
675 HYPOPHAGIA 25 0.0010
676 POLYURIA 8 0.0010
677 ATRIAL FIBRILLATION 94 0.0010
678 RASH PUSTULAR 7 0.0010
679 RESPIRATORY TRACT INFECTION 25 0.0010
680 MYOCARDITIS 11 0.0010
681 OSTEOMYELITIS 17 0.0009
682 HYPERGLYCAEMIA 34 0.0009
683 BLOOD MAGNESIUM DECREASED 8 0.0009
684 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
685 PULMONARY CONGESTION 12 0.0009
686 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
687 PANCREATITIS 48 0.0009
688 CARDIOGENIC SHOCK 13 0.0009
689 CYSTIC FIBROSIS 5 0.0009
690 HALLUCINATION, VISUAL 19 0.0009
691 HEPATIC ENZYME INCREASED 61 0.0009
692 HAEMOLYTIC ANAEMIA 8 0.0009
693 CYANOSIS 14 0.0009
694 CARDIOMYOPATHY 13 0.0009
695 NEUTROPHILIA 5 0.0009
696 ECCHYMOSIS 6 0.0009
697 ORAL HERPES 17 0.0009
698 RESPIRATORY DISORDER 26 0.0009
699 HERPES VIRUS INFECTION 5 0.0009
700 TACHYCARDIA 77 0.0009
701 HYPOGLYCAEMIA 42 0.0009
702 BLOOD POTASSIUM INCREASED 14 0.0009
703 LIVER FUNCTION TEST ABNORMAL 25 0.0009
704 CARDIAC FAILURE 69 0.0009
705 ABNORMAL FAECES 7 0.0009
706 OXYGEN SATURATION DECREASED 48 0.0009
707 HICCUPS 7 0.0009
708 CYSTITIS 27 0.0008
709 DIALYSIS 12 0.0008
710 CONDITION AGGRAVATED 257 0.0008
711 PLATELET COUNT INCREASED 11 0.0008
712 EOSINOPHIL COUNT INCREASED 7 0.0008
713 HAEMATEMESIS 21 0.0008
714 ASPIRATION 9 0.0008
715 FACIAL PARALYSIS 7 0.0008
716 HAEMATURIA 28 0.0008
717 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 19 0.0008
718 BLOOD POTASSIUM DECREASED 24 0.0008
719 APHASIA 24 0.0008
720 RESPIRATORY RATE INCREASED 7 0.0008
721 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
722 JAUNDICE 21 0.0008
723 SINUS TACHYCARDIA 11 0.0008
724 RASH ERYTHEMATOUS 37 0.0008
725 RED BLOOD CELL COUNT DECREASED 22 0.0008
726 HAEMOGLOBIN DECREASED 79 0.0008
727 HEPATITIS ACUTE 5 0.0008
728 PARALYSIS 11 0.0008
729 GASTROINTESTINAL INFLAMMATION 6 0.0008
730 LYMPHADENOPATHY 27 0.0008
731 IRON DEFICIENCY ANAEMIA 7 0.0008
732 RENAL CYST 6 0.0008
733 HERPES ZOSTER 43 0.0007
734 BODY TEMPERATURE INCREASED 15 0.0007
735 SKIN LESION 20 0.0007
736 HEMIPLEGIA 6 0.0007
737 PULMONARY HYPERTENSION 15 0.0007
738 EPILEPSY 22 0.0007
739 OEDEMA 39 0.0007
740 RENAL DISORDER 33 0.0007
741 EJECTION FRACTION DECREASED 11 0.0007
742 BRAIN INJURY 7 0.0007
743 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
744 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
745 DISEASE RECURRENCE 33 0.0007
746 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
747 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
748 VENTRICULAR EXTRASYSTOLES 7 0.0007
749 MYOSITIS 6 0.0007
750 BLOOD PRESSURE FLUCTUATION 16 0.0007
751 HEPATITIS 17 0.0007
752 INCONTINENCE 7 0.0007
753 RESPIRATORY ARREST 18 0.0007
754 OVARIAN CANCER 6 0.0007
755 CARDIOMEGALY 8 0.0006
756 GASTRITIS 17 0.0006
757 CARDIO-RESPIRATORY ARREST 27 0.0006
758 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
759 HEPATOCELLULAR INJURY 9 0.0006
760 BLOOD PRESSURE DECREASED 42 0.0006
761 COMA 30 0.0006
762 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
763 EMBOLISM 5 0.0006
764 HAEMODIALYSIS 5 0.0006
765 CHOLECYSTITIS 7 0.0006
766 MYOPATHY 5 0.0006
767 THERAPY PARTIAL RESPONDER 9 0.0006
768 NO THERAPEUTIC RESPONSE 7 0.0006
769 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
770 MOUTH ULCERATION 12 0.0006
771 ABDOMINAL PAIN 132 0.0006
772 HALLUCINATION, AUDITORY 9 0.0006
773 BRADYCARDIA 30 0.0006
774 PLASMA CELL MYELOMA 22 0.0006
775 ISCHAEMIC STROKE 10 0.0006
776 INFUSION RELATED REACTION 37 0.0006
777 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
778 ARRHYTHMIA 26 0.0005
779 END STAGE RENAL DISEASE 10 0.0005
780 IMPAIRED HEALING 18 0.0005
781 HAEMATOCHEZIA 30 0.0005
782 IMMUNODEFICIENCY 8 0.0005
783 FACE OEDEMA 9 0.0005
784 STATUS EPILEPTICUS 6 0.0005
785 DERMATITIS CONTACT 6 0.0005
786 PRODUCTIVE COUGH 25 0.0005
787 HYPERTENSION 110 0.0005
788 UVEITIS 7 0.0005
789 URINARY RETENTION 17 0.0005
790 ATAXIA 6 0.0005
791 MYOCLONUS 6 0.0005
792 POLYNEUROPATHY 6 0.0005
793 PRESYNCOPE 12 0.0005
794 SEIZURE 57 0.0005
795 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
796 BRONCHOSPASM 7 0.0005
797 LUNG DISORDER 24 0.0005
798 GASTROENTERITIS 7 0.0005
799 RHABDOMYOLYSIS 20 0.0005
800 PALLOR 13 0.0005
801 BLOOD SODIUM DECREASED 9 0.0005
802 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
803 DIARRHOEA 300 0.0005
804 HIATUS HERNIA 6 0.0005
805 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
806 FLUID RETENTION 23 0.0005
807 HAEMORRHAGE 47 0.0004
808 ORAL PAIN 10 0.0004
809 DEEP VEIN THROMBOSIS 29 0.0004
810 CHROMATURIA 10 0.0004
811 ACUTE MYOCARDIAL INFARCTION 13 0.0004
812 DRUG TOXICITY 6 0.0004
813 MYOCARDIAL ISCHAEMIA 5 0.0004
814 RESTLESSNESS 16 0.0004
815 GASTRIC HAEMORRHAGE 5 0.0004
816 NEOPLASM PROGRESSION 15 0.0004
817 COORDINATION ABNORMAL 6 0.0004
818 ANAPHYLACTIC SHOCK 11 0.0004
819 SKIN ULCER 11 0.0004
820 GLAUCOMA 8 0.0004
821 EPISTAXIS 31 0.0004
822 NOCTURIA 5 0.0004
823 RENAL INJURY 12 0.0004
824 ABDOMINAL DISTENSION 42 0.0004
825 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
826 VIRAL INFECTION 13 0.0004
827 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
828 INFLAMMATION 20 0.0004
829 HAEMATOMA 10 0.0004
830 PRODUCT USE ISSUE 72 0.0004
831 DERMATITIS 8 0.0004
832 ANAPHYLACTIC REACTION 21 0.0004
833 IMMUNE SYSTEM DISORDER 5 0.0004
834 PULMONARY EMBOLISM 36 0.0004
835 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
836 LABORATORY TEST ABNORMAL 11 0.0004
837 HEPATIC CIRRHOSIS 7 0.0004
838 SINUSITIS 38 0.0004
839 COVID-19 65 0.0004
840 FAECES DISCOLOURED 8 0.0004
841 CHILLS 43 0.0004
842 IMPAIRED GASTRIC EMPTYING 5 0.0004
843 PHOTOSENSITIVITY REACTION 6 0.0004
844 THERAPEUTIC RESPONSE DECREASED 22 0.0004
845 EXTRAPYRAMIDAL DISORDER 9 0.0004
846 PRESCRIBED OVERDOSE 7 0.0004
847 PERICARDITIS 6 0.0004
848 TOXICITY TO VARIOUS AGENTS 60 0.0004
849 VOMITING 167 0.0004
850 URINARY TRACT INFECTION 60 0.0004
851 RECTAL HAEMORRHAGE 15 0.0003
852 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
853 INFLUENZA 37 0.0003
854 DIVERTICULITIS 9 0.0003
855 HEPATIC STEATOSIS 6 0.0003
856 OEDEMA PERIPHERAL 39 0.0003
857 DYSPNOEA EXERTIONAL 12 0.0003
858 DYSPNOEA 179 0.0003
859 GASTRIC ULCER 6 0.0003
860 PROTEINURIA 6 0.0003
861 CONVULSION 18 0.0003
862 HYPOTHYROIDISM 10 0.0003
863 POST PROCEDURAL COMPLICATION 6 0.0003
864 CONFUSIONAL STATE 50 0.0003
865 DEAFNESS 8 0.0003
866 RASH 132 0.0003
867 DYSURIA 11 0.0003
868 FULL BLOOD COUNT DECREASED 6 0.0003
869 LETHARGY 17 0.0003
870 THROMBOSIS 23 0.0003
871 DEATH 246 0.0003
872 AMENORRHOEA 5 0.0003
873 BRONCHITIS 21 0.0003
874 COUGH 78 0.0003
875 CHRONIC KIDNEY DISEASE 21 0.0003
876 CONSTIPATION 60 0.0003
877 BONE PAIN 16 0.0003
878 DYSKINESIA 11 0.0003
879 BLISTER 15 0.0003
880 DYSARTHRIA 10 0.0003
881 GASTROINTESTINAL DISORDER 23 0.0003
882 DEHYDRATION 34 0.0003
883 DISORIENTATION 10 0.0003
884 PROCEDURAL PAIN 7 0.0003
885 NEUROPATHY PERIPHERAL 24 0.0003
886 BLOOD PRESSURE ABNORMAL 5 0.0003
887 LOSS OF CONSCIOUSNESS 32 0.0002
888 DECREASED APPETITE 58 0.0002
889 OROPHARYNGEAL PAIN 22 0.0002
890 NAUSEA 188 0.0002
891 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
892 EATING DISORDER 5 0.0002
893 LACRIMATION INCREASED 7 0.0002
894 ERYTHEMA 47 0.0002
895 SWELLING 21 0.0002
896 HEART RATE IRREGULAR 5 0.0002
897 NO ADVERSE EVENT 40 0.0002
898 CHOLELITHIASIS 7 0.0002
899 SKIN EXFOLIATION 18 0.0002
900 BLOOD GLUCOSE INCREASED 40 0.0002
901 PAIN IN JAW 6 0.0002
902 MENTAL DISORDER 9 0.0002
903 TREMOR 34 0.0002
904 PREMATURE BABY 6 0.0002
905 CARDIAC FAILURE CONGESTIVE 16 0.0002
906 ILL-DEFINED DISORDER 12 0.0002
907 PALPITATIONS 23 0.0002
908 CHEST DISCOMFORT 20 0.0002
909 INSOMNIA 51 0.0002
910 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
911 WEIGHT DECREASED 53 0.0002
912 RASH PRURITIC 10 0.0002
913 ADVERSE EVENT 17 0.0002
914 SYNCOPE 18 0.0002
915 SKIN DISORDER 6 0.0002
916 DYSPHAGIA 17 0.0002
917 SOMNOLENCE 36 0.0002
918 CHEST PAIN 33 0.0002
919 UNDERDOSE 13 0.0002
920 AGITATION 13 0.0002
921 BACK PAIN 40 0.0002
922 DIABETES MELLITUS 13 0.0002
923 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
924 DRUG INTOLERANCE 16 0.0002
925 BALANCE DISORDER 14 0.0002
926 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
927 VISUAL IMPAIRMENT 20 0.0002
928 HALLUCINATION 12 0.0002
929 INTESTINAL OBSTRUCTION 6 0.0002
930 RHINORRHOEA 10 0.0002
931 VISION BLURRED 21 0.0002
932 MUSCULAR WEAKNESS 17 0.0001
933 ASTHENIA 55 0.0001
934 WEIGHT INCREASED 32 0.0001
935 ARTHRITIS 11 0.0001
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
937 SWELLING FACE 9 0.0001
938 INTENTIONAL PRODUCT MISUSE 12 0.0001
939 ABDOMINAL PAIN UPPER 28 0.0001
940 HEADACHE 83 0.0001
941 SKIN DISCOLOURATION 6 0.0001
942 TREATMENT NONCOMPLIANCE 7 0.0001
943 BLINDNESS 5 0.0001
944 OVERDOSE 26 0.0001
945 HYPERHIDROSIS 15 0.0001
946 SPEECH DISORDER 6 0.0001
947 HYPOAESTHESIA 17 0.0001
948 ANGIOEDEMA 5 0.0001
949 MYALGIA 19 0.0001
950 BLOOD PRESSURE INCREASED 17 0.0001
951 PAIN IN EXTREMITY 31 0.0001
952 DYSPHONIA 6 0.0001
953 FALL 34 0.0001
954 PRURITUS 39 0.0001
955 CATARACT 6 0.0001
956 CEREBROVASCULAR ACCIDENT 17 0.0001
957 DRY EYE 5 0.0001
958 SLEEP DISORDER 7 0.0001
959 HOSPITALISATION 15 0.0001
960 MOBILITY DECREASED 7 0.0001
961 HYPERSENSITIVITY 18 0.0001
962 EXPOSURE DURING PREGNANCY 6 0.0001
963 MUSCULOSKELETAL PAIN 5 0.0001
964 PAIN 57 0.0001
965 MALAISE 40 0.0001
966 FATIGUE 71 0.0001
967 HEART RATE INCREASED 9 0.0001
968 URTICARIA 15 0.0001
969 NECK PAIN 5 0.0001
970 EYE PAIN 5 0.0001
971 ILLNESS 9 0.0001
972 CARDIAC DISORDER 8 0.0001
973 ABDOMINAL DISCOMFORT 14 0.0001
974 GAIT DISTURBANCE 15 0.0001
975 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
976 INFLUENZA LIKE ILLNESS 6 0.0001
977 DIZZINESS 36 0.0001
978 PARAESTHESIA 11 0.0001
979 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
980 MUSCLE SPASMS 12 0.0001
981 PERIPHERAL SWELLING 10 0.0001
982 ANXIETY 18 0.0001
983 ARTHRALGIA 26 0.0001
984 CONTUSION 6 0.0001
985 ALOPECIA 11 0.0001
986 ASTHMA 6 0.0001
987 MYOCARDIAL INFARCTION 9 0.0001
988 PRODUCT DOSE OMISSION ISSUE 15 0.0001
989 DYSPEPSIA 5 0.0001
990 NASOPHARYNGITIS 9 0.0000
991 DEPRESSION 10 0.0000
992 INCORRECT DOSE ADMINISTERED 9 0.0000
993 MEMORY IMPAIRMENT 5 0.0000
994 DRUG DOSE OMISSION 5 0.0000